FR2000281A1 - Compn contng polyestriol phosphate for treatment of - Google Patents

Compn contng polyestriol phosphate for treatment of

Info

Publication number
FR2000281A1
FR2000281A1 FR6900505A FR6900505A FR2000281A1 FR 2000281 A1 FR2000281 A1 FR 2000281A1 FR 6900505 A FR6900505 A FR 6900505A FR 6900505 A FR6900505 A FR 6900505A FR 2000281 A1 FR2000281 A1 FR 2000281A1
Authority
FR
France
Prior art keywords
contng
compn
treatment
iii
polyestriol phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6900505A
Other languages
French (fr)
Inventor
Birger Ferno Ove
Jacob Fex Hans
Bertil Hogberg Knut
Konyves Imre
Ove Enok Linderot Torsten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo AB
Original Assignee
Leo AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo AB filed Critical Leo AB
Publication of FR2000281A1 publication Critical patent/FR2000281A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Injectable soln. contng. polyestriol phosphate (I), a local anaesthetic (II) and a solubilising agent (III) at pH 6.3-7.5. Treatment of menopause symptoms. The compns. show prolonged effects. (1-2 months between injections). Compn. conts. 2-12% (I), 0.25-4% (II) and 0.75-12% (III). (II) may be mepivacaine, chloroprocaine, menocaine, piperocaine, procaine, or lidocaine, and (III) may be nicotinamide, morpholine, diethanolamine, diethylamine, ethanolamine or dimethylaminoethanol. Dose: 20-100 mg(I).
FR6900505A 1968-01-16 1969-01-15 Compn contng polyestriol phosphate for treatment of Withdrawn FR2000281A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69815268A 1968-01-16 1968-01-16

Publications (1)

Publication Number Publication Date
FR2000281A1 true FR2000281A1 (en) 1969-09-05

Family

ID=24804122

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6900505A Withdrawn FR2000281A1 (en) 1968-01-16 1969-01-15 Compn contng polyestriol phosphate for treatment of

Country Status (2)

Country Link
BE (1) BE726959A (en)
FR (1) FR2000281A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB778142A (en) * 1953-11-20 1957-07-03 Leo Ab High-molecular weight derivatives of hydroxyl group-containing steroids and a method of producing them

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB778142A (en) * 1953-11-20 1957-07-03 Leo Ab High-molecular weight derivatives of hydroxyl group-containing steroids and a method of producing them

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LA *REVUE "UNLISTED DRUGS", 1968, PAGE 8C CITE: "MBR. INTERKANT KONTR. HEILM." 67:415, SEPT. 67 *

Also Published As

Publication number Publication date
BE726959A (en) 1969-07-01

Similar Documents

Publication Publication Date Title
ATE168560T1 (en) TOPICAL AGENTS FOR TRANSDERMAL ADMINISTRATION OF PRODRUG DERIVATIVES OF MORPHINE
DK0735868T3 (en) Use of non-steroidal cyclooxygenase inhibitors for the manufacture of a medicament for the treatment of elevated intracellular
CO4290359A1 (en) METHOD FOR TREATING ANDROGENIC ALOPECIA WITH 5-ALPHA-REDUCTASE INHIBITORS
ES8607021A1 (en) Solutions of lactic acid salts of piperazinylquinolone and piperazinyl azaquinolonecarboxylic acids
ES362679A1 (en) 3-keto-delta 4-9alpha-halo-11-oxygenated-16-methyl or methylene-17alpha-acyloxy-20-keto-21-halo pregnenes
FI51350C (en) Process for the preparation of urinary excretion-promoting 6-sulfamyl-1,2,3,4-tetrahydro-4-quinazolinones and their salts.
DE69033970D1 (en) HUPERZIN A ANALOGUE CONNECTIONS
AU563831B2 (en) N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives
GB1390803A (en) Medicinal tampons and compositions containing lactulose
ES395640A1 (en) Carbaliphatic-oxy aminophenylamidines
JPS5767518A (en) Radiosensitizing agent or agent for increasing effect of radiomimetic substance
ATE76579T1 (en) INTERFERON COMPOSITIONS.
ATE289819T1 (en) MEMORY IMPROVEMENT BY ADMINISTRATION OF DELTA-5-ANDROSTEN-3-BETA-OL-7,17-DIONE AND 3-BETA-ESTERS OF THE SAME
HK17880A (en) N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide and derivatives
ES2162794T3 (en) PHARMACEUTICAL COMPOUNDS CONTAINING AMETOCAINE.
ES368398A1 (en) Propanolamine derivatives
GB1036059A (en) Improvements in or relating to the inhibition of bacterial growth
PARK et al. Study on the Spermatic cord Block in Intrascrotal Surgery
USD164058S (en) Peery bed
BE759304Q (en) Phenoxyalkylamines coronary vasodilators and
USD169776S (en) Mcmurdo eyeshade
ES370500A1 (en) PROCEDURE FOR THE PREPARATION OF THE HYDRACID.
FR2081402A1 (en) Combatting picorna virus with a substdethane diol
FR2398497A1 (en) Synergistic compsns. for treatment of chronic bronchitis - contg. S-carboxy methyl cysteine and a penicillin or cephalosporin
JPS51118282A (en) Turnout system for conveyor line

Legal Events

Date Code Title Description
ST Notification of lapse